These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5883465)

  • 21. Unexpected sensitivity of tumor cells to cyclophosphamide in one-day-old solid Ehrlich ascites tumors.
    Urano M; Tanaka N; Shirakura I
    Gan; 1970 Aug; 61(4):353-8. PubMed ID: 5454682
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cytostatic-testing with the particle counter TuR ZG 1].
    Gutsche W
    Arzneimittelforschung; 1968 Feb; 18(2):258-9. PubMed ID: 5695392
    [No Abstract]   [Full Text] [Related]  

  • 23. Host interactions in the effects of 5-fluorouracil on Ehrlich ascites tumor cells.
    Connolly KM; Armstrong RD; Diasio RB; Kaplan AM
    Cancer Res; 1982 Dec; 42(12):4927-35. PubMed ID: 6754072
    [No Abstract]   [Full Text] [Related]  

  • 24. Antitumor activity of an alkylating derivative of dipyridamole.
    Andreani A; Bossa R; Fraccari A; Galatulas I; Ninci MA; Rambaldi M
    Anticancer Res; 1996; 16(4A):1831-3. PubMed ID: 8712709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The action of Fleming's lysozyme compared to the antieoplastic action of cyclophosphamide in the treatment of experimental Ehrlich carcinoma of the oral cavity].
    Gambetti G
    Mondo Odontostomatol; 1967; 9(6):660-71. PubMed ID: 5240604
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
    Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
    Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in the state of plasma membrane proteins of tumor cells exposed to a polyene antibiotic and cyclophosphamide].
    Oksman AIa; Shneĭder MA; Eremeeva AA; Karel'skaia NP; Tereshin IM
    Antibiotiki; 1981 Sep; 26(9):692-4. PubMed ID: 7294761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis, cytostatic activity and mechanism of action of N-glycosylhalomethylazoles. A new class of alkylating agents].
    Alonso G; Alonso R; Camarasa MJ; Contreras A; García López MT; de las Heras FG; Herranz R; Sánchez-Pérez RM
    Rev Esp Oncol; 1982; 29(4):603-7. PubMed ID: 6927609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of levorin on the activity of facilitated diffusion systems in murine Ehrlich cancer cells].
    Lishnevskaia EB; Gorozhankina IS; Tereshin IM
    Antibiotiki; 1982 Feb; 27(2):141-4. PubMed ID: 7065649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of immunosuppressive pretreatment on the survival of mice challenged with Ehrlich ascites carcinoma (EAC).
    Jakóbisiak M; Lasek W; Kańtoch M; Rozmysłowicz T
    Neoplasma; 1980; 27(2):147-50. PubMed ID: 7393355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of glycyrrhizin on the evolution and respiration of Ehrlich ascites tumour cells.
    Rossi T; Galatulas I; Bossa R; Tampieri A; Tartoni P; Baggio G; Ruberto AI; Castelli M
    In Vivo; 1995; 9(3):183-6. PubMed ID: 8562878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspects of chalone action.
    Lehmann W; Graetz H; Schunck H; Schütt M; Langen P
    Acta Histochem Suppl; 1983; 27():63-71. PubMed ID: 6223337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synchronization of Ehrlich ascites tumor cells and its importance in the use of an alkylating cytostatic agent].
    Klein HO; Lennartz KJ; Habicht W; Eder M; Gross R
    Klin Wochenschr; 1970 Aug; 48(16):1001-5. PubMed ID: 5519404
    [No Abstract]   [Full Text] [Related]  

  • 35. Melatonin shortens the survival rate of Ehrlich ascites-inoculated mice.
    Catrina SB; Curca E; Catrina AI; Radu C; Coculescu M
    Neuro Endocrinol Lett; 2001 Dec; 22(6):432-4. PubMed ID: 11781540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of cyclophosphamide and 1-methylnitrosourea on Ehrlich carcinoma transplanted in different sites. Correlation between drug level and tumor inhibition.
    Bossi A; Colombo T; Donelli MG; Garattini S
    Biochem Pharmacol; 1975 Jan; 24(1):21-6. PubMed ID: 1122258
    [No Abstract]   [Full Text] [Related]  

  • 37. [Change in the cell cycle in a population of Ehrlich ascitic tumor cells as affected by an antiblastoma preparation].
    Dubinskaia SN; Zelenkova NP; Zaikonnikova IV; Studenkotsova IA
    Tsitol Genet; 1983; 17(2):54-8. PubMed ID: 6679411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression of histone acetylation by alkylating antitumor agents in murine cells.
    Zwierzina H; Loidl A; Fuith LC; Helliger W; Puschendorf B; Grunicke H
    Cancer Res; 1984 Aug; 44(8):3336-9. PubMed ID: 6744267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Ehrlich ascites tumor cell growth by Griffonia simplicifolia I lectin in vivo.
    Eckhardt AE; Malone BN; Goldstein IJ
    Cancer Res; 1982 Aug; 42(8):2977-9. PubMed ID: 7093946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.